Single-agent gemcitabine as second-line treatment in patients with advanced non small cell lung cancer (NSCLC): A phase II trial

C. Gridelli, F. Perrone, C. Gallo, A. Rossi, E. Barletta, M. L. Barzelloni, S. Creazzola, T. Gatani, F. Fiore, C. Guida, F. Scognamiglio

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Single-agent gemcitabine as second-line treatment in patients with advanced non small cell lung cancer (NSCLC): A phase II trial'. Together they form a unique fingerprint.

Medicine & Life Sciences